Table 2.
Serious AE (Includes All Grades, Any Attribution)
| Category | Toxicity Type | Grade 1/2 | Grade 3 | Grade 4 | Grade 5 | Total |
|---|---|---|---|---|---|---|
| Dose level 1 (n = 3) | ||||||
| Gastrointestinal disorders | Abdominal pain | 0 | 1 | 0 | 0 | 1 |
| Dose level 1 (n = 10) | ||||||
| General disorders and administration site conditions | Disease progression | 0 | 0 | 0 | 1 | 1 |
| Respiratory, thoracic, and mediastinal disorders | Dyspnea | 0 | 0 | 2 | 0 | 2 |
| Metabolism and nutrition disorders | Hypercalcemia | 0 | 0 | 1 | 0 | 1 |
| Metabolism and nutrition disorders | Hypokalemia | 0 | 0 | 1 | 0 | 1 |
| Blood and lymphatic system disorders | Neutropenia | 0 | 1 | 1 | 0 | 2 |
| Skin and subcutaneous tissue disorders | Pruritus | 0 | 1 | 0 | 0 | 1 |
| Respiratory, thoracic, and mediastinal disorders | Respiratory failure | 0 | 0 | 0 | 2 | 2 |
| Infections and infestations | Urinary tract infection | 1 | 0 | 0 | 0 | 1 |
AE, adverse event.